Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,940,151
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
11,783,583
-
Shares change
-
+3,182,363
-
Total reported value, excl. options
-
$224,000,755
-
Value change
-
+$60,010,242
-
Number of buys
-
48
-
Number of sells
-
7
-
Price
-
$19.01
Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q4 2019
As of 31 Dec 2019 TransMedics Group, Inc. - Common Stock (TMDX) had 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,783,583 shares of stock of the company.
Largest 10 holders included ABRAMS CAPITAL MANAGEMENT, L.P., CREDIT SUISSE AG/, BlackRock Inc., Sandhill Capital Partners LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, Zimmer Partners, LP, EMERALD ADVISERS, LLC, and EMERALD MUTUAL FUND ADVISERS TRUST.
This table shows 65 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.